Clinical Trials Logo

Testicular Neoplasms clinical trials

View clinical trials related to Testicular Neoplasms.

Filter by:

NCT ID: NCT06133543 Recruiting - Germ Cell Tumor Clinical Trials

Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer

RAISN
Start date: September 6, 2023
Phase: N/A
Study type: Interventional

Robot-assisted image-guided sentinel lymph node biopsy (RAISN) in testicular cancer is a novel technique that has not been widely investigated yet. This technique is promising and could be implemented as a future standard in the primary diagnostic work up of clinical stage (CS) I testicular cancer. Current staging strategies have a poor predictive accuracy for occult metastatic disease. So far, feasibility studies used 99mTC-nanocolloid staining and laparoscopy and all patients with tumor-positive nodes received adjuvant systemic treatment. The development of a robot-assisted image-guided lymph node resection technique with indocyanine green (ICG) is potentially more precise, easier to apply and widely available. With this new diagnostic approach the management of newly diagnosed testicular cancer patients might be changed dramatically by reducing overtreatment and treatment-related toxicity with a minimally invasive robot-assisted procedure.

NCT ID: NCT06060873 Recruiting - Clinical trials for Malignant Testicular Germ Cell Tumor

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

Start date: June 8, 2023
Phase:
Study type: Observational

This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.

NCT ID: NCT06044220 Completed - Testicular Neoplasm Clinical Trials

Testicular Self-examination Training Given to Students

Start date: December 21, 2021
Phase: N/A
Study type: Interventional

The aim of this quasi-experimental control group study was to evaluate the effectiveness of testicular self-examination training given to male university students. Hypotheses; H1a: Immediately after the training and three months after the training, the experimental and control groups' Planned Behavior Theory scale intention sub-dimension scores related to Testicular Self-Examination will increase. H1b: Immediately after the training and three months after the training, the experimental and control groups' Planned Behavior Theory scale attitude sub-dimension scores related to Testicular Self-Examination will increase. H1c: Immediately after the training and three months after the training, the experimental and control groups' Planned Behavior Theory scale subjective norm sub-dimension scores on Testicular Self-Examination will increase. H1d: Immediately after the training and three months after the training, the experimental and control groups' Planned Behavior Theory scale perceived behavioral control sub-dimension scores will increase. H1e: Immediately after the training and three months after the training, the scores of the Planned Behavior Theory scale self-efficacy sub-dimension related to Testicular Self-Examination will increase in the experimental and control groups. H1f: Immediately after the training and three months after the training, the experimental and control group's Planned Behavior Theory scale total scores on Testicular Self-Examination will increase. A questionnaire will be administered to the participants before and after the training of male health promotion and testicular self-examination, and the retest will be filled after the reminders about the smallpox given for 3 months. The researcher will compare the intervention and control group to see if the behavior of performing testicular self-examination regularly occurs.

NCT ID: NCT05946993 Recruiting - Prostate Cancer Clinical Trials

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

LIAM Mc
Start date: May 8, 2023
Phase: N/A
Study type: Interventional

To evaluate the feasibility of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary malignancies.

NCT ID: NCT05928377 Not yet recruiting - Testicular Cancer Clinical Trials

Unveiling Patient Experiences in Testicular Cancer Clinical Trials

Start date: July 2024
Phase:
Study type: Observational

Clinical research participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about testicular cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with testicular cancer who are invited to take part in medical research will benefit from the analysis of the data.

NCT ID: NCT05899361 Recruiting - Prostate Cancer Clinical Trials

A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

This research study is a pilot clinical trial, which hypothesizes that the combination of electromagnetic tracking in conjunction with laparoscope imaging and ultrasound probe imaging will aid in reducing the complexity of both laparoscopic lymphadenectomy and/or organ removal in patients with a confirmed diagnosis of cancer in urologic regions of interest (Bladder, Prostate, Testicular, Kidney, Urethral, and Penis), by resulting in better visualization and more accurate localization of certain areas in the diseased organ or the diseased lymph node, and allowing for improved surgical and patient outcomes, fewer complications and better clinician performance.

NCT ID: NCT05840575 Recruiting - Cancer Clinical Trials

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

MyBrain
Start date: March 1, 2022
Phase:
Study type: Observational

The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.

NCT ID: NCT05836688 Recruiting - Testicular Cancer Clinical Trials

A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

This study is a randomized controlled biobehavioral efficacy trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET) aimed at improving distress symptoms, emotion regulation, goal navigation skills, and stress-sensitive biomarkers in young adult testicular cancer patients. Participants will be randomized to receive six sessions of GET or Individual Supportive Listening (ISL) delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary (depressive and anxiety symptoms) and secondary (emotion regulation and goal navigation skills, career confusion) psychological outcomes prior to (T0), immediately after (T1), twelve weeks after intervention (T2) and 24 weeks after the intervention (T3). Additionally, identified biomarkers will be measured at baseline and at T1, T2, and T3.

NCT ID: NCT05819827 Recruiting - Prostate Cancer Clinical Trials

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Start date: April 19, 2023
Phase:
Study type: Observational

The objective of this pilot cohort study is to investigate associations between CIN and changes in gut microbiome composition profiles.

NCT ID: NCT05670938 Recruiting - Quality of Life Clinical Trials

Follow-up After Surgery for Testicular Cancer

FUTURE-testis
Start date: November 30, 2022
Phase:
Study type: Observational

The currently developed implementation study aims to evaluate if a patient-led home-based follow-up approach is successful, improves quality of life, reduces anxiety and lessens fear of cancer recurrence during the years after treatment of certain types of testicular cancer.